Medical device maker Tornier (NASDAQ:TRNX), which makes orthopedics products for extremities including the shoulder and ankle, announced Friday that it is acquiring OrthoHelix Surgical Designs, an Ohio company, for $135 million. Tornier, based in Bloomington, Minnesota, said that it will make additional payments over two years based on the acquiree achieving certain revenue goals. The transaction […]
Medical device maker Tornier announced Friday that it will close some of its operations in the U.S. and Europe and consolidate the work to other locations. The company that makes surgical products for orthopedic extremity specialists said that it will consolidate its distribution center in Stafford, Texas to Minnesota. Tornier plans to consolidate Texas operations […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
For those people in the beleaguered medical device industry who think they will fare better under a more Republican Congress, think again. As the industry and its allies in the U.S. Senate try to mitigate the Food and Drug Administration's plans to tighten the 510(k) program, the incoming Republican chairman of a powerful House investigatory committee is taking aim at medical devices.
Medtronic Inc. hasn’t had much luck of late with orthopedics, particularly its spine business. But if Tornier Inc.’s planned $205 million initial public offering comes to fruition, the country’s largest medical device maker is looking at a huge pay day. The Bakken Research Center (BRC) in Maastricht, Netherlands, home to Medtronic’s R&D operations in Europe, […]
Tornier Inc. is planning to test the choppy waters of Wall Street with an estimated $205 million initial public offering, according to documents filed with the Securities and Exchange Commission. The orthopedics firm in Edina, Minn., which specializes in devices to treat injuries to extremities and small bones, is the third local medical device company […]
The deal marks the first investment out of NEP's $1.2 billion Fund IX, which closed September 2008. What makes the deal even more interesting is NEP's partnership with Split Rock, a prominent venture capital firm based in Eden Prairie.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.